Pharmaceuticals Companies By Shares Shorted

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Number Of Shares Shorted
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Number Of Shares ShortedEfficiencyMarket RiskExp Return
1TLRY Tilray Inc
108.65 M
(0.12)
 3.40 
(0.40)
2PFE Pfizer Inc
90.38 M
(0.06)
 1.56 
(0.09)
3ZOM Zomedica Pharmaceuticals Corp
51.14 M
(0.01)
 4.06 
(0.05)
4MRK Merck Company
32.79 M
(0.17)
 1.25 
(0.21)
5BMY Bristol Myers Squibb
25.6 M
 0.13 
 2.02 
 0.26 
6TEVA Teva Pharma Industries
22.41 M
 0.12 
 3.85 
 0.45 
7VTRS Viatris
20.6 M
 0.09 
 2.22 
 0.20 
8GSK GlaxoSmithKline PLC ADR
19.35 M
(0.17)
 1.54 
(0.27)
9JNJ Johnson Johnson
18.54 M
(0.17)
 0.83 
(0.14)
10SAVA Cassava Sciences
17.16 M
(0.19)
 11.99 
(2.29)
11CORT Corcept Therapeutics Incorporated
17.05 M
 0.12 
 2.81 
 0.32 
12RPRX Royalty Pharma Plc
15.7 M
(0.14)
 1.08 
(0.15)
13ELAN Elanco Animal Health
15.58 M
(0.08)
 2.63 
(0.22)
14CTLT Catalent
14.74 M
 0.15 
 0.65 
 0.10 
15PHAT Phathom Pharmaceuticals
14.05 M
(0.19)
 5.91 
(1.14)
16OGN Organon Co
13.68 M
(0.18)
 2.03 
(0.36)
17RVNC Revance
12.7 M
(0.08)
 7.25 
(0.57)
18RDY Dr Reddys Laboratories
11.04 M
(0.02)
 1.41 
(0.03)
19INVA Innoviva
10.73 M
(0.08)
 1.03 
(0.09)
20OCUL Ocular Therapeutix
10.66 M
 0.00 
 3.67 
 0.01 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up. If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY